TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
842
|
2,683 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
-677
|
35
|
1,995 |
EBITDA |
-703
|
180
|
2,008 |
Total assets |
2,023
|
3,176
|
3,251 |
Current assets |
2,023
|
2,610
|
2,517 |
Current liabilities |
119
|
761
|
789 |
Equity capital |
1,880
|
2,254
|
2,297 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
|
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.9%
|
71.0%
|
70.7% |
Turnover per employee |
0
|
842
|
2,683 |
Profit as a percentage of turnover |
4.2%
|
74.4% | |
Return on assets (ROA) |
-33.4%
|
1.1%
|
61.4% |
Current ratio |
1700%
|
343.0%
|
319.0% |
Return on equity (ROE) |
-36.0%
|
1.6%
|
86.9% |
Change turnover |
-902
|
-1,760
|
1,976 |
Change turnover % |
-100%
|
-68%
|
279% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
100%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.